Publications

1. Ng ABCD, Asif A, Agarwal R, Panebianco V, Girometti R, Ghai S, Gomez-Gomez E, Budaus L, Barrett T, Radtke JP, Kesch C, De Cobelli F, Pham T, Taneja SS, Hu JC, Tewari A, Rodriguez Cabello MA, Dias AB, Mynderse LA, Borghi M, Boesen L, Singh P, Renard-Penna R, Leow JJ, Falkenbach F, Pecoraro M, Giannarini G, Perlis N, Lopez-Ruiz D, Kastner C, Schimmoller L, Rossiter M, Nathan A, Khetrapal P, Chan VW, Haider A, Clarke CS, Punwani S, Brew-Graves C, Dickinson L, Mitra A, Brembilla G, Margolis DJA, Takwoingi Y, Emberton M, Allen C, Giganti F, Moore CM, Kasivisvanathan V, PRIME Study Group Collaborators. Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial. JAMA. 2025 Sep 10 Epub 2025 Sept 10
   View PubMed
2. Whalen S, Woodrum D, Thompson S, Adamo D, Lomas D, Mynderse L. In-Bore MRI-Guided Ureteral Stent Placement During Prostate Cancer Cryoablation-A Case Series. Diagnostics (Basel). 2025 Jul 15; 15 (14) Epub 2025 July 15
   View PubMed
3. Whalen S, Woodrum D, Thompson S, Adamo D, Lomas D, Mynderse L. In-Bore MRI-Guided Ureteral Stent Placement During Prostate Cancer Cryoablation-A Case Series. Diagnostics (Basel). 2025 Jul 15; 15 (14) Epub 2025 July 15
   View PubMed
4. Sotoudehnia S, Leung BYC, Thompson SM, Adamo DA, Mynderse LA, Woodrum DA. Saline Displacement of Rectal Wall for Improved Margin During MRI-Guided Transurethral Ultrasound Ablation (TULSA). Cardiovasc Intervent Radiol. 2025 Jun 24 Epub 2025 June 24
   View PubMed
5. Sotoudehnia S, Leung BYC, Thompson SM, Adamo DA, Mynderse LA, Woodrum DA. Saline Displacement of Rectal Wall for Improved Margin During MRI-Guided Transurethral Ultrasound Ablation (TULSA). Cardiovasc Intervent Radiol. 2025 Jun 24 Epub 2025 June 24
   View PubMed
6. Takahashi H, Nakai H, Ballman KV, Lomas DJ, Mynderse LA, Kawashima A, Huang S, Legout JD, Young JR, Thorpe MP, Johnson GB, Karnes RJ, Sartor AO, Takahashi N. Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3. Abdom Radiol (NY). 2025 Jun 3 Epub 2025 June 03
   View PubMed
7. Takahashi H, Nakai H, Ballman KV, Lomas DJ, Mynderse LA, Kawashima A, Huang S, Legout JD, Young JR, Thorpe MP, Johnson GB, Karnes RJ, Sartor AO, Takahashi N. Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3. Abdom Radiol (NY). 2025 Jun 3 Epub 2025 June 03
   View PubMed
8. Koo K, Cooper MA, Lomas DJ, Mynderse LA, Potretzke AM, Wymer KM. Evidence-Based Framework for Surgical Irrigation Fluid Stewardship and Endoscopic Case Prioritization During Fluid Shortages. Urol Pract. 2025 May; 12 (3):293-297 Epub 2025 Jan 25
   View PubMed
9. Koo K, Cooper MA, Lomas DJ, Mynderse LA, Potretzke AM, Wymer KM. Evidence-Based Framework for Surgical Irrigation Fluid Stewardship and Endoscopic Case Prioritization During Fluid Shortages. Urol Pract. 2025 May; 12 (3):293-297 Epub 2025 Jan 25
   View PubMed
10. Martin A, Mahmoud AM, Britton CJ, Fadel A, Ahmed ME, Sharma V, Childs DS, Johnson GB, Davis BJ, Mynderse L, Lomas D, Woodrum D, Frendl D, Karnes JR, Tollefson MK, Kwon ED, Andrews JR. In-field prostate cancer recurrence following radical prostatectomy and salvage radiation. BJU Int. 2025 Apr; 135 (4):668-674 Epub 2024 Nov 30
    View PubMed
11. Martin A, Mahmoud AM, Britton CJ, Fadel A, Ahmed ME, Sharma V, Childs DS, Johnson GB, Davis BJ, Mynderse L, Lomas D, Woodrum D, Frendl D, Karnes JR, Tollefson MK, Kwon ED, Andrews JR. In-field prostate cancer recurrence following radical prostatectomy and salvage radiation. BJU Int. 2025 Apr; 135 (4):668-674 Epub 2024 Nov 30
    View PubMed
12. Mushtaq A, Mynderse L, Thompson S, Adamo D, Lomas D, Favazza C, Lu A, Kwon E, Woodrum D. Magnetic Resonance Imaging-Guided Cryoablation of Prostate Cancer Lymph Node Metastasis. J Vasc Interv Radiol. 2024 Oct; 35 (10):1474-1480 Epub 2024 June 22
    View PubMed
13. Kuanar S, Cai J, Nakai H, Nagayama H, Takahashi H, LeGout J, Kawashima A, Froemming A, Mynderse L, Dora C, Humphreys M, Klug J, Korfiatis P, Erickson B, Takahashi N. Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer. Abdom Radiol (NY). 2024 Oct; 49 (10):3722-3734 Epub 2024 June 19
    View PubMed
14. Mushtaq A, Mynderse L, Thompson S, Adamo D, Lomas D, Favazza C, Lu A, Kwon E, Woodrum D. Magnetic Resonance Imaging-Guided Cryoablation of Prostate Cancer Lymph Node Metastasis. J Vasc Interv Radiol. 2024 Oct; 35 (10):1474-1480 Epub 2024 June 22
    View PubMed
15. Kuanar S, Cai J, Nakai H, Nagayama H, Takahashi H, LeGout J, Kawashima A, Froemming A, Mynderse L, Dora C, Humphreys M, Klug J, Korfiatis P, Erickson B, Takahashi N. Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer. Abdom Radiol (NY). 2024 Oct; 49 (10):3722-3734 Epub 2024 June 19
    View PubMed
16. Cai JC, Nakai H, Kuanar S, Froemming AT, Bolan CW, Kawashima A, Takahashi H, Mynderse LA, Dora CD, Humphreys MR, Korfiatis P, Rouzrokh P, Bratt AK, Conte GM, Erickson BJ, Takahashi N. Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI. Radiology. 2024 Aug; 312 (2):e232635
    View PubMed
17. Cai JC, Nakai H, Kuanar S, Froemming AT, Bolan CW, Kawashima A, Takahashi H, Mynderse LA, Dora CD, Humphreys MR, Korfiatis P, Rouzrokh P, Bratt AK, Conte GM, Erickson BJ, Takahashi N. Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI. Radiology. 2024 Aug; 312 (2):e232635
    View PubMed
18. Nagayama H, Nakai H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI Performed for Clinical Suspicion of Prostate Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):398-408 Epub 2023 Oct 10
    View PubMed
19. Nakai H, Nagayama H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):387-397 Epub 2023 Oct 12
    View PubMed
20. Nagayama H, Nakai H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI Performed for Clinical Suspicion of Prostate Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):398-408 Epub 2023 Oct 10
    View PubMed
21. Nakai H, Nagayama H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):387-397 Epub 2023 Oct 12
    View PubMed
22. Deol ES, Tollefson MK, Antolin A, Zohar M, Bar O, Ben-Ayoun D, Mynderse LA, Lomas DJ, Avant RA, Miller AR, Elliott DS, Boorjian SA, Wolf T, Asselmann D, Khanna A. Automated surgical step recognition in transurethral bladder tumor resection using artificial intelligence: transfer learning across surgical modalities. Front Artif Intell. 2024; 7:1375482 Epub 2024 Mar 07
    View PubMed
23. Deol ES, Tollefson MK, Antolin A, Zohar M, Bar O, Ben-Ayoun D, Mynderse LA, Lomas DJ, Avant RA, Miller AR, Elliott DS, Boorjian SA, Wolf T, Asselmann D, Khanna A. Automated surgical step recognition in transurethral bladder tumor resection using artificial intelligence: transfer learning across surgical modalities. Front Artif Intell. 2024; 7:1375482 Epub 2024 Mar 07
    View PubMed
24. Foroughi P, Rajan P, Hobbach M, Demir A, Hammelmann J, Harlan K, Mushtaq A, Mynderse LA, Woodrum DA. Evaluation of a perineal access device for MRI-guided prostate interventions. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2023; 12466:124660J
    
25. Foroughi P, Rajan P, Hobbach M, Demir A, Hammelmann J, Harlan K, Mushtaq A, Mynderse LA, Woodrum DA. Evaluation of a perineal access device for MRI-guided prostate interventions. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2023; 12466:124660J
    
26. Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh QD, Durack JC, Akin O, Vickers AJ, Scardino PT, Sperling D, Wong JYC, Yuh B, Woodrum DA, Mynderse LA, Raman SS, Pantuck AJ, Schiffman MH, McClure TD, Sonn GA, Ghanouni P. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol. 2022 Jul; 23 (7):910-918 Epub 2022 June 14
    View PubMed
27. Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh QD, Durack JC, Akin O, Vickers AJ, Scardino PT, Sperling D, Wong JYC, Yuh B, Woodrum DA, Mynderse LA, Raman SS, Pantuck AJ, Schiffman MH, McClure TD, Sonn GA, Ghanouni P. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol. 2022 Jul; 23 (7):910-918 Epub 2022 June 14
    View PubMed
28. Tanaka T, Kawashima A, Rangel LJ, Schulte PJ, Froemming AT, King BF, Mynderse LA, Karnes RJ. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy. J Urol. 2022 May; 207 (5):1038-1047 Epub 2022 Jan 04
    View PubMed
29. Tanaka T, Kawashima A, Rangel LJ, Schulte PJ, Froemming AT, King BF, Mynderse LA, Karnes RJ. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy. J Urol. 2022 May; 207 (5):1038-1047 Epub 2022 Jan 04
    View PubMed
30. Takahashi H, Yoshida K, Kawashima A, Lee NJ, Froemming AT, Adamo DA, Khandelwal A, Bolan CW, Heller MT, Hartman RP, Kim B, Philbrick KA, Carter RE, Mynderse LA, Humphreys MR, Cai JC, Takahashi N. Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23
    View PubMed
31. Takahashi H, Yoshida K, Kawashima A, Lee NJ, Froemming AT, Adamo DA, Khandelwal A, Bolan CW, Heller MT, Hartman RP, Kim B, Philbrick KA, Carter RE, Mynderse LA, Humphreys MR, Cai JC, Takahashi N. Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23
    View PubMed
32. Gupta S, Lipworth R, Mynderse LA. Papillary Urothelial Carcinoma. Mayo Clin Proc. 2021 Nov; 96 (11):2746-2747
    View PubMed
33. Gupta S, Lipworth R, Mynderse LA. Papillary Urothelial Carcinoma. Mayo Clin Proc. 2021 Nov; 96 (11):2746-2747
    View PubMed
34. Rosen DP, Husmann DA, Mynderse LA, Kelly TF Jr, Alizad A, Fatemi M. Detrusor overactivity assessment using ultrasound bladder vibrometry. Physiol Meas. 2021 Oct 29; 42(10).
    View PubMed
35. Rosen DP, Husmann DA, Mynderse LA, Kelly TF Jr, Alizad A, Fatemi M. Detrusor overactivity assessment using ultrasound bladder vibrometry. Physiol Meas. 2021 Oct 29; 42(10).
    View PubMed
36. Thompson SM, Gorny KR, Koepsel EMK, Welch BT, Mynderse L, Lu A, Favazza CP, Felmlee JP, Woodrum DA. Body Interventional MRI for Diagnostic and Interventional Radiologists: Current Practice and Future Prospects. Radiographics. 2021 Oct; 41 (6):1785-1801
    View PubMed
37. Thompson SM, Gorny KR, Koepsel EMK, Welch BT, Mynderse L, Lu A, Favazza CP, Felmlee JP, Woodrum DA. Body Interventional MRI for Diagnostic and Interventional Radiologists: Current Practice and Future Prospects. Radiographics. 2021 Oct; 41 (6):1785-1801
    View PubMed
38. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Reply by Authors. J Urol 2021 Sep; 206 (3):724 Epub 2021 June 02
    View PubMed
39. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021 Sep; 206 (3):715-724 Epub 2021 Apr 19
    View PubMed
40. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Reply by Authors. J Urol 2021 Sep; 206 (3):724 Epub 2021 June 02
    View PubMed
41. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021 Sep; 206 (3):715-724 Epub 2021 Apr 19
    View PubMed
42. Breen WG, Stish BJ, Harmsen WS, Froemming AT, Mynderse LA, Choo CR, Davis BJ, Pisansky TM. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer. Radiother Oncol. 2021 Aug; 161:9-15 Epub 2021 May 21
    View PubMed
43. Breen WG, Stish BJ, Harmsen WS, Froemming AT, Mynderse LA, Choo CR, Davis BJ, Pisansky TM. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer. Radiother Oncol. 2021 Aug; 161:9-15 Epub 2021 May 21
    View PubMed
44. Ahmed ME, Andrews JR, Joshi VB, Mynderse LA, Tollefson MK, Karnes RJ, Kwon ED. Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):689-692 Epub 2021 May 26
    View PubMed
45. Ahmed ME, Andrews JR, Joshi VB, Mynderse LA, Tollefson MK, Karnes RJ, Kwon ED. Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):689-692 Epub 2021 May 26
    View PubMed
46. Lomas DJ, Woodrum DA, Mynderse LA. Salvage ablation for locally recurrent prostate cancer. Curr Opin Urol. 2021 May 1; 31 (3):188-193
    View PubMed
47. Lu A, Favazza CP, Felmlee JP, Welch BT, Mynderse LA, Browne JE, Woodrum DA, Gorny KR. Experimental Investigation of Cryoneedle Heating during MR-Guided Cryoablation in Ex Vivo Tissue Samples at 1.5-Tesla. J Vasc Interv Radiol. 2021 May; 32 (5):721-728.e2 Epub 2021 Mar 02
    View PubMed
48. Lomas DJ, Woodrum DA, Mynderse LA. Salvage ablation for locally recurrent prostate cancer. Curr Opin Urol. 2021 May 1; 31 (3):188-193
    View PubMed
49. Lu A, Favazza CP, Felmlee JP, Welch BT, Mynderse LA, Browne JE, Woodrum DA, Gorny KR. Experimental Investigation of Cryoneedle Heating during MR-Guided Cryoablation in Ex Vivo Tissue Samples at 1.5-Tesla. J Vasc Interv Radiol. 2021 May; 32 (5):721-728.e2 Epub 2021 Mar 02
    View PubMed
50. Zhang X, Husmann DA, Mynderse LA, Alizad A, Fatemi M. Non-invasive assessment of urinary bladder compliance using ultrasound: first validation study based on clinical urodynamic study. Ann Transl Med. 2021 Apr; 9 (7):547
    View PubMed
51. Zhang X, Husmann DA, Mynderse LA, Alizad A, Fatemi M. Non-invasive assessment of urinary bladder compliance using ultrasound: first validation study based on clinical urodynamic study. Ann Transl Med. 2021 Apr; 9 (7):547
    View PubMed
52. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Reply by authors Journal of Urology. 2021; 206 (3):724
    
53. McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. Reply by authors Journal of Urology. 2021; 206 (3):724
    
54. Santus E, Schuster T, Tahmasebi AM, Li C, Yala A, Lanahan CR, Prinsen P, Thompson SF, Coons S, Mynderse L, Barzilay R, Hughes K. Exploiting Rules to Enhance Machine Learning in Extracting Information From Multi-Institutional Prostate Pathology Reports. JCO Clin Cancer Inform. 2020 Oct; 4:865-874
    View PubMed
55. Santus E, Schuster T, Tahmasebi AM, Li C, Yala A, Lanahan CR, Prinsen P, Thompson SF, Coons S, Mynderse L, Barzilay R, Hughes K. Exploiting Rules to Enhance Machine Learning in Extracting Information From Multi-Institutional Prostate Pathology Reports. JCO Clin Cancer Inform. 2020 Oct; 4:865-874
    View PubMed
56. Lomas DJ, Woodrum DA, McLaren RH, Gorny KR, Felmlee JP, Favazza C, Lu A, Mynderse LA. Rectal wall saline displacement for improved margin during MRI-guided cryoablation of primary and recurrent prostate cancer. Abdom Radiol (NY). 2020 Apr; 45 (4):1155-1161
    View PubMed
57. Lomas DJ, Woodrum DA, McLaren RH, Gorny KR, Felmlee JP, Favazza C, Lu A, Mynderse LA. Rectal wall saline displacement for improved margin during MRI-guided cryoablation of primary and recurrent prostate cancer. Abdom Radiol (NY). 2020 Apr; 45 (4):1155-1161
    View PubMed
58. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Magnetic Resonance-Guided Prostate Ablation. Semin Intervent Radiol. 2019 Dec; 36 (5):351-366 Epub 2019 Dec 02
    View PubMed
59. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Magnetic Resonance-Guided Prostate Ablation. Semin Intervent Radiol. 2019 Dec; 36 (5):351-366 Epub 2019 Dec 02
    View PubMed
60. Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, Karnes RJ, Kwon ED, Davis BJ. (11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):659-667 Epub 2019 July 04
    View PubMed
61. Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, Karnes RJ, Kwon ED, Davis BJ. (11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):659-667 Epub 2019 July 04
    View PubMed
62. Wymer KM, Sharma V, Davis BJ, Kwon ED, Mynderse LA, Karnes RJ. Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence. Clin Genitourin Cancer. 2019 Jun; 17 (3):e536-e540 Epub 2019 Feb 06
    View PubMed
63. Wymer KM, Sharma V, Davis BJ, Kwon ED, Mynderse LA, Karnes RJ. Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence. Clin Genitourin Cancer. 2019 Jun; 17 (3):e536-e540 Epub 2019 Feb 06
    View PubMed
64. Merrell KW, Davis BJ, Goulet CC, Furutani KM, Mynderse LA, Harmsen WS, Wilson TM, McLaren RH, Deufel CL, Birckhead BJ, Funk RK, McMenomy BP, Stish BJ, Choo CR. Reducing seed migration to near zero with stranded-seed implants: Comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds. Brachytherapy. 2019 May - Jun; 18 (3):306-312 Epub 2019 Mar 08
    View PubMed
65. Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE. Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer. J Natl Compr Canc Netw. 2019 May 1; 17 (5):506-513
    View PubMed
66. Merrell KW, Davis BJ, Goulet CC, Furutani KM, Mynderse LA, Harmsen WS, Wilson TM, McLaren RH, Deufel CL, Birckhead BJ, Funk RK, McMenomy BP, Stish BJ, Choo CR. Reducing seed migration to near zero with stranded-seed implants: Comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds. Brachytherapy. 2019 May - Jun; 18 (3):306-312 Epub 2019 Mar 08
    View PubMed
67. Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE. Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer. J Natl Compr Canc Netw. 2019 May 1; 17 (5):506-513
    View PubMed
68. Bayat M, Adabi S, Kumar V, Gregory A, Webb J, Denis M, Kim B, Singh A, Mynderse L, Husmann D, Alizad A, Fatemi M. Acoustoelasticity Analysis of Transient Waves for Non-Invasive In Vivo Assessment of Urinary Bladder. Sci Rep. 2019 Feb 21; 9 (1):2441
    View PubMed
69. Bayat M, Adabi S, Kumar V, Gregory A, Webb J, Denis M, Kim B, Singh A, Mynderse L, Husmann D, Alizad A, Fatemi M. Acoustoelasticity Analysis of Transient Waves for Non-Invasive In Vivo Assessment of Urinary Bladder. Sci Rep. 2019 Feb 21; 9 (1):2441
    View PubMed
70. Routman DM, Funk RK, Stish BJ, Mynderse LA, Wilson TM, McLaren R, Harmsen WS, Mara K, Deufel CL, Furutani KM, Haddock MG, Pisansky TM, Choo CR, Davis BJ. Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients. Brachytherapy. 2019 Jan - Feb; 18 (1):1-7 Epub 2018 Oct 04
    View PubMed
71. Routman DM, Funk RK, Stish BJ, Mynderse LA, Wilson TM, McLaren R, Harmsen WS, Mara K, Deufel CL, Furutani KM, Haddock MG, Pisansky TM, Choo CR, Davis BJ. Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients. Brachytherapy. 2019 Jan - Feb; 18 (1):1-7 Epub 2018 Oct 04
    View PubMed
72. Welch BT, Packard AT, Atwell TD, Johnson GB, Lowe VJ, Karnes RJ, Mynderse LA, Gunderson TM, Park SS, Stish BJ, Evans JD, Kwon ED, Davis BJ, Nathan MA. Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):79-89 Epub 2018 Sept 05
    View PubMed
73. Welch BT, Packard AT, Atwell TD, Johnson GB, Lowe VJ, Karnes RJ, Mynderse LA, Gunderson TM, Park SS, Stish BJ, Evans JD, Kwon ED, Davis BJ, Nathan MA. Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):79-89 Epub 2018 Sept 05
    View PubMed
74. Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Eur Urol. 2018 Jun; 73 (6):879-887 Epub 2017 Nov 28
    View PubMed
75. Stish BJ, Davis BJ, Mynderse LA, McLaren RH, Deufel CL, Choo R. Low dose rate prostate brachytherapy. Transl Androl Urol. 2018 Jun; 7 (3):341-356
    View PubMed
76. Woodrum DA, Gorny KR, Mynderse LA. MR-Guided Prostate Interventions. Top Magn Reson Imaging. 2018 Jun; 27 (3):141-151
    View PubMed
77. Woodrum DA, Gorny KR, Mynderse LA. MR-Guided Prostate Interventions. Top Magn Reson Imaging. 2018 Jun; 27 (3):141-151
    View PubMed
78. Stish BJ, Davis BJ, Mynderse LA, McLaren RH, Deufel CL, Choo R. Low dose rate prostate brachytherapy. Transl Androl Urol. 2018 Jun; 7 (3):341-356
    View PubMed
79. Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Eur Urol. 2018 Jun; 73 (6):879-887 Epub 2017 Nov 28
    View PubMed
80. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budaus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM, PRECISION Study Group Collaborators. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 May 10; 378 (19):1767-1777 Epub 2018 Mar 18
    View PubMed
81. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budaus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM, PRECISION Study Group Collaborators. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 May 10; 378 (19):1767-1777 Epub 2018 Mar 18
    View PubMed
82. Kargar S, Borisch EA, Froemming AT, Kawashima A, Mynderse LA, Stinson EG, Trzasko JD, Riederer SJ. Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate. Magn Reson Imaging. 2018 May; 48:50-61 Epub 2017 Dec 24
    View PubMed
83. Kargar S, Borisch EA, Froemming AT, Kawashima A, Mynderse LA, Stinson EG, Trzasko JD, Riederer SJ. Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate. Magn Reson Imaging. 2018 May; 48:50-61 Epub 2017 Dec 24
    View PubMed
84. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using (11)C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging. J Urol. 2018 Mar; 199 (3):726-733 Epub 2017 Sept 12
    View PubMed
85. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using (11)C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging. J Urol. 2018 Mar; 199 (3):726-733 Epub 2017 Sept 12
    View PubMed
86. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of recurrence sites following post-prostatectomy treatment for prostate cancer using c-11-choline positron emission tomography and multiparametric pelvic magnetic resonance imaging Journal Of Urology. 2018 Mar; 199 (3):726-33
    
87. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of recurrence sites following post-prostatectomy treatment for prostate cancer using c-11-choline positron emission tomography and multiparametric pelvic magnetic resonance imaging Journal Of Urology. 2018 Mar; 199 (3):726-33
    
88. Kinsman KA, White ML, Mynderse LA, Kawashima A, Rampton K, Gorny KR, Atwell TD, Felmlee JP, Callstrom MR, Woodrum DA. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up. Cardiovasc Intervent Radiol. 2018 Feb; 41 (2):344-349 Epub 2017 Oct 17
    View PubMed
89. Kinsman KA, White ML, Mynderse LA, Kawashima A, Rampton K, Gorny KR, Atwell TD, Felmlee JP, Callstrom MR, Woodrum DA. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up. Cardiovasc Intervent Radiol. 2018 Feb; 41 (2):344-349 Epub 2017 Oct 17
    View PubMed
90. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer. Adv Exp Med Biol. 2018; 1096:159-184
    View PubMed
91. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer. Adv Exp Med Biol. 2018; 1096:159-184
    View PubMed
92. Wilhite TJ, Routman D, Arnett AL, Glasgow AE, Habermann EB, Pisansky TM, Boorjian SA, Jethwa KR, Mynderse LA, Roberts KW, Frank I, Choo R, Davis BJ, Stish BJ. Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis. Bladder (San Franc). 2018; 5 (3):e34 Epub 2018 Aug 23
    View PubMed
93. Wilhite TJ, Routman D, Arnett AL, Glasgow AE, Habermann EB, Pisansky TM, Boorjian SA, Jethwa KR, Mynderse LA, Roberts KW, Frank I, Choo R, Davis BJ, Stish BJ. Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis. Bladder (San Franc). 2018; 5 (3):e34 Epub 2018 Aug 23
    View PubMed
94. Morlacco A, Murphy CR, Rangel LJ, Mynderse LA, Thompson RH, Karnes RJ. Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Specimen. Urol Pract. 2018 Jan; 5 (1):76-82 Epub 2016 Dec 07
    View PubMed
95. Morlacco A, Murphy CR, Rangel LJ, Mynderse LA, Thompson RH, Karnes RJ. Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Specimen. Urol Pract. 2018 Jan; 5 (1):76-82 Epub 2016 Dec 07
    View PubMed
96. Olson MC, Atwell TD, Mynderse LA, King BF, Welch T, Goenka AH. CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience. Eur Radiol. 2017 Aug; 27 (8):3326-3332 Epub 2016 Dec 14
    View PubMed
97. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Prostate cancer: state of the art imaging and focal treatment. Clin Radiol. 2017 Aug; 72: (8)665-679.
    View PubMed
98. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Prostate cancer: state of the art imaging and focal treatment. Clin Radiol. 2017 Aug; 72: (8)665-679.
    View PubMed
99. Olson MC, Atwell TD, Mynderse LA, King BF, Welch T, Goenka AH. CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience. Eur Radiol. 2017 Aug; 27 (8):3326-3332 Epub 2016 Dec 14
    View PubMed
100. Stish BJ, Davis BJ, Mynderse LA, Deufel CL, Choo R. Brachytherapy in the Management of Prostate Cancer. Surg Oncol Clin N Am. 2017 Jul; 26 (3):491-513 Epub 2017 May 11
     View PubMed
101. Stish BJ, Davis BJ, Mynderse LA, Deufel CL, Choo R. Brachytherapy in the Management of Prostate Cancer. Surg Oncol Clin N Am. 2017 Jul; 26 (3):491-513 Epub 2017 May 11
     View PubMed
102. Riederer SJ, Borisch EA, Froemming AT, Grimm RC, Kawashima A, Mynderse LA, Trzasko JD. Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array. Magn Reson Imaging. 2017 Jun; 39:15-23 Epub 2017 Jan 27
     View PubMed
103. Riederer SJ, Borisch EA, Froemming AT, Grimm RC, Kawashima A, Mynderse LA, Trzasko JD. Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array. Magn Reson Imaging. 2017 Jun; 39:15-23 Epub 2017 Jan 27
     View PubMed
104. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71 (3):340-348 Epub 2016 Sept 03
     View PubMed
105. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 1; 97 (3):526-535 Epub 2016 Nov 17
     View PubMed
106. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 1; 97 (3):526-535 Epub 2016 Nov 17
     View PubMed
107. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71 (3):340-348 Epub 2016 Sept 03
     View PubMed
108. Bayat M, Kumar V, Denis M, Webb J, Gregory A, Mehrmohammadi M, Cheong M, Husmann D, Mynderse L, Alizad A, Fatemi M. Correlation of ultrasound bladder vibrometry assessment of bladder compliance with urodynamic study results. PLoS One. 2017; 12 (6):e0179598 Epub 2017 June 16
     View PubMed
109. Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil. Pract Radiat Oncol. 2017 Jan - Feb; 7 (1):42-49 Epub 2016 June 14
     View PubMed
110. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary mapping of post-prostatectomy prostate cancer relapse with c-11-choline positron emission tomography and multiparametric magnetic resonance imaging Journal Of Urology. 2017 Jan; 197(1):129-34. Epub 1900 Jan 01.
     
111. Bayat M, Kumar V, Denis M, Webb J, Gregory A, Mehrmohammadi M, Cheong M, Husmann D, Mynderse L, Alizad A, Fatemi M. Correlation of ultrasound bladder vibrometry assessment of bladder compliance with urodynamic study results. PLoS One. 2017; 12 (6):e0179598 Epub 2017 June 16
     View PubMed
112. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with (11)C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. J Urol. 2017 Jan; 197 (1):129-134 Epub 2016 July 20
     View PubMed
113. Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil. Pract Radiat Oncol. 2017 Jan - Feb; 7 (1):42-49 Epub 2016 June 14
     View PubMed
114. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with (11)C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. J Urol. 2017 Jan; 197 (1):129-134 Epub 2016 July 20
     View PubMed
115. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary mapping of post-prostatectomy prostate cancer relapse with c-11-choline positron emission tomography and multiparametric magnetic resonance imaging Journal Of Urology. 2017 Jan; 197(1):129-34. Epub 1900 Jan 01.
     
116. Zattoni F, Nehra A, Murphy CR, Rangel L, Mynderse L, Lowe V, Kwon E, Karnes RJ. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy. Eur Urol Focus. 2016 Dec; 2 (5):522-531 Epub 2016 Feb 10
     View PubMed
117. Zattoni F, Nehra A, Murphy CR, Rangel L, Mynderse L, Lowe V, Kwon E, Karnes RJ. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy. Eur Urol Focus. 2016 Dec; 2 (5):522-531 Epub 2016 Feb 10
     View PubMed
118. Birckhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray. Brachytherapy. 2016 Nov - Dec; 15 (6):714-721 Epub 2016 Aug 16
     View PubMed
119. Birekhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by day 0 fluoroscopy and 4-month postimplant pelvic x-ray Brachytherapy. 2016 Nov-dec; 15: (6)714-21.
     
120. Birekhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by day 0 fluoroscopy and 4-month postimplant pelvic x-ray Brachytherapy. 2016 Nov-dec; 15: (6)714-21.
     
121. Birckhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray. Brachytherapy. 2016 Nov - Dec; 15 (6):714-721 Epub 2016 Aug 16
     View PubMed
122. McLaren RH, Mynderse LA, Davis BJ, Kwon ED, Lowe VJ, Nathan MA, Karnes R, Parker WP. The Utility of C11 Choline PET/CT in Post-prostatectomy Patients with Biochemical Recurrence: a Comparison to mpMRI. World Jnl of Urol.2016;().
     
123. McLaren RH, Mynderse LA, Davis BJ, Kwon ED, Lowe VJ, Nathan MA, Karnes R, Parker WP. The Utility of C11 Choline PET/CT in Post-prostatectomy Patients with Biochemical Recurrence: a Comparison to mpMRI. World Jnl of Urol.2016;().
     
124. Jethwa KR, Furutani KM, Mynderse LA, Wilson TM, Choo R, King BF, Bergstralh E, Davis BJ. Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression. J Contemp Brachytherapy. 2016 Oct; 8 (5):371-378 Epub 2016 Nov 04
     View PubMed
125. Jethwa KR, Furutani KM, Mynderse LA, Wilson TM, Choo R, King BF, Bergstralh E, Davis BJ. Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression. J Contemp Brachytherapy. 2016 Oct; 8 (5):371-378 Epub 2016 Nov 04
     View PubMed
126. Woodrum DA, Gorny KR, Greenwood B, Mynderse LA. MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer. Semin Intervent Radiol. 2016 Sep; 33 (3):196-205
     View PubMed
127. Woodrum DA, Gorny KR, Greenwood B, Mynderse LA. MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer. Semin Intervent Radiol. 2016 Sep; 33 (3):196-205
     View PubMed
128. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study". J Sex Med 2016 Jun; 13 (6):936-7
     View PubMed
129. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study". J Sex Med 2016 Jun; 13 (6):936-7
     View PubMed
130. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. J Sex Med. 2016 Jun; 13 (6):924-33 Epub 2016 Apr 27
     View PubMed
131. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. J Sex Med. 2016 Jun; 13 (6):924-33 Epub 2016 Apr 27
     View PubMed
132. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
     View PubMed
133. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Targeted prostate biopsy and MR-guided therapy for prostate cancer. Abdom Radiol (NY). 2016 May; 41 (5):877-88
     View PubMed
134. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2016 May; 195 (5):1529-1538 Epub 2015 Nov 22
     View PubMed
135. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
     View PubMed
136. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Targeted prostate biopsy and MR-guided therapy for prostate cancer. Abdom Radiol (NY). 2016 May; 41 (5):877-88
     View PubMed
137. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2016 May; 195 (5):1529-1538 Epub 2015 Nov 22
     View PubMed
138. Cheong M, Denis M, Kumar V, Mehrmohammadi M, Gregory A, Nenadic I, Husmann D, Mynderse L, Alizad A, Fatemi M. Clinical results of ultrasound bladder vibrometry for assessment of bladder compliance Journal of the Acoustical Society of America. 2016; 139(4 pt 2):2176.
     
139. Cheong M, Denis M, Kumar V, Mehrmohammadi M, Gregory A, Nenadic I, Husmann D, Mynderse L, Alizad A, Fatemi M. Clinical results of ultrasound bladder vibrometry for assessment of bladder compliance Journal of the Acoustical Society of America. 2016; 139(4 pt 2):2176.
     
140. Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Larson TR, Mynderse LA. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016; 8:207-216 Epub 2016 Nov 21
     View PubMed
141. Nenadic I, Mynderse L, Husmann D, Mehrmohammadi M, Bayat M, Singh A, Denis M, Urban M, Alizad A, Fatemi M. Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment. PLoS One. 2016; 11 (6):e0157818 Epub 2016 June 24
     View PubMed
142. Nenadic I, Mynderse L, Husmann D, Mehrmohammadi M, Bayat M, Singh A, Denis M, Urban M, Alizad A, Fatemi M. Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment. PLoS One. 2016; 11 (6):e0157818 Epub 2016 June 24
     View PubMed
143. Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Larson TR, Mynderse LA. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016; 8:207-216 Epub 2016 Nov 21
     View PubMed
144. Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Mynderse L, Larson T. Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology. 2015 Nov; 86 (5):1042-7 Epub 2015 July 26
     View PubMed
145. Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Mynderse L, Larson T. Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology. 2015 Nov; 86 (5):1042-7 Epub 2015 July 26
     View PubMed
146. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer. Magn Reson Imaging Clin N Am. 2015 Nov; 23: (4)607-19.
     View PubMed
147. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer. Magn Reson Imaging Clin N Am. 2015 Nov; 23: (4)607-19.
     View PubMed
148. Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Cedano ER, Woodrum DA, Dixon CM, Larson TR. Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings. Urology. 2015 Jul; 86 (1):122-7 Epub 2015 May 16
     View PubMed
149. Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Cedano ER, Woodrum DA, Dixon CM, Larson TR. Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings. Urology. 2015 Jul; 86 (1):122-7 Epub 2015 May 16
     View PubMed
150. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2015 Feb; 115 (2):295-9
     View PubMed
151. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2015 Feb; 115 (2):295-9
     View PubMed
152. Karnes RJ, Murphy CR, Bergstralh EJ, DiMonte G, Cheville JC, Lowe VJ, Mynderse LA, Kwon ED. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. J Urol. 2015 Jan; 193 (1):111-6 Epub 2014 Aug 20
     View PubMed
153. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015; 7:13-8 Epub 2015 Jan 30
     View PubMed
154. Karnes RJ, Murphy CR, Bergstralh EJ, DiMonte G, Cheville JC, Lowe VJ, Mynderse LA, Kwon ED. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. J Urol. 2015 Jan; 193 (1):111-6 Epub 2014 Aug 20
     View PubMed
155. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015; 7:13-8 Epub 2015 Jan 30
     View PubMed
156. Holmes DR 3rd, Davis BJ, Goulet CC, Wilson TM, Mynderse LA, Furutani KM, Camp JJ, Robb RA. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance. Brachytherapy. 2014 Sep-Oct; 13 (5):465-70 Epub 2014 June 21
     View PubMed
157. Holmes DR 3rd, Davis BJ, Goulet CC, Wilson TM, Mynderse LA, Furutani KM, Camp JJ, Robb RA. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance. Brachytherapy. 2014 Sep-Oct; 13 (5):465-70 Epub 2014 June 21
     View PubMed
158. Favazza CP, Gorny KR, King DM, Rossman PJ, Felmlee JP, Woodrum DA, Mynderse LA. An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology. 2014 Aug; 69(1):128-33. Epub 2014 Jun 27.
     View PubMed
159. Favazza CP, Gorny KR, King DM, Rossman PJ, Felmlee JP, Woodrum DA, Mynderse LA. An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology. 2014 Aug; 69(1):128-33. Epub 2014 Jun 27.
     View PubMed
160. Ahmed KA, Davis BJ, Mynderse LA, Slezak JM, Bergstralh EJ, Wilson TM, Choo CR. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol. 2014 Jul 29; 9:171 Epub 2014 July 29
     View PubMed
161. Ahmed KA, Davis BJ, Mynderse LA, Slezak JM, Bergstralh EJ, Wilson TM, Choo CR. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol. 2014 Jul 29; 9:171 Epub 2014 July 29
     View PubMed
162. Davis BJ, Leenstra JL, Wilson TM, Mynderse LA, Solhjem MC, Herman MG, Hillman DW, Allen-Ziegler KL, Cheville JC, King BF, Holmes III DR. Prostate Volume in Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Imaging and Treatment Devices for the Prostate. OMICS J Radiol S1. June 6, 2014(S1).
     
163. Davis BJ, Leenstra JL, Wilson TM, Mynderse LA, Solhjem MC, Herman MG, Hillman DW, Allen-Ziegler KL, Cheville JC, King BF, Holmes III DR. Prostate Volume in Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Imaging and Treatment Devices for the Prostate. OMICS J Radiol S1. June 6, 2014(S1).
     
164. Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, Rangel LJ, King BF, Mynderse LA. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol. 2014 Jun; 21 (3):7283-9
     View PubMed
165. Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, Rangel LJ, King BF, Mynderse LA. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol. 2014 Jun; 21 (3):7283-9
     View PubMed
166. Yelfimov D, Mynderse LA, Tollefson MK. In Vivo magnetic resonance elastography to image prostate anatomy in patients with prostate cancer: a feasibility study J Urol. 2014.
     
167. Yelfimov D, Mynderse LA, Tollefson MK. In Vivo magnetic resonance elastography to image prostate anatomy in patients with prostate cancer: a feasibility study J Urol. 2014.
     
168. Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Mayo Clin Proc. 2014 Mar; 89 (3):308-18 Epub 2014 Jan 31
     View PubMed
169. Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Mayo Clin Proc. 2014 Mar; 89 (3):308-18 Epub 2014 Jan 31
     View PubMed
170. Mitchell CR, Mynderse LA, Lightner DJ, Husmann DA, Krambeck AE. Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology. 2014 Feb; 83(2):428-32. Epub 2013 Nov 12.
     View PubMed
171. Mitchell CR, Mynderse LA, Lightner DJ, Husmann DA, Krambeck AE. Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology. 2014 Feb; 83(2):428-32. Epub 2013 Nov 12.
     View PubMed
172. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2014; 115(2):295-9.
     
173. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2014; 115(2):295-9.
     
174. Mehrmohammadi M, Nenadic IZ, Urban MW, Greenleaf JF, Alizad A, Husmann DA, Mynderse LA, Fatemi M. Ultrasound bladder vibrometry for evaluation of bladder compliance: Preliminary in vivo results. J Acoust Soc Am. 2013 Nov; 134(5):4011.
     
175. Mehrmohammadi M, Nenadic IZ, Urban MW, Greenleaf JF, Alizad A, Husmann DA, Mynderse LA, Fatemi M. Ultrasound bladder vibrometry for evaluation of bladder compliance: Preliminary in vivo results. J Acoust Soc Am. 2013 Nov; 134(5):4011.
     
176. Woodrum DA, Kawashima A, Karnes RJ, Davis BJ, Frank I, Engen DE, Gorny KR, Felmlee JP, Callstrom MR, Mynderse LA. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology. 2013 Oct; 82 (4):870-5 Epub 2013 Aug 01
     View PubMed
177. Woodrum DA, Kawashima A, Karnes RJ, Davis BJ, Frank I, Engen DE, Gorny KR, Felmlee JP, Callstrom MR, Mynderse LA. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology. 2013 Oct; 82 (4):870-5 Epub 2013 Aug 01
     View PubMed
178. Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol. 2013 Apr; 189 (4):1347-51 Epub 2012 Nov 15
     View PubMed
179. Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol. 2013 Apr; 189 (4):1347-51 Epub 2012 Nov 15
     View PubMed
180. Alizad A, Mehrmohammadi M, Mitri FG, Davis BJ, Sebo TJ, Mynderse LA, Kinnick RR, Greenleaf JF, Fatemi M. Application of vibro-acoustography in prostate tissue imaging. Med Phys. 2013 Feb; 40 (2):022902
     View PubMed
181. Alizad A, Mehrmohammadi M, Mitri FG, Davis BJ, Sebo TJ, Mynderse LA, Kinnick RR, Greenleaf JF, Fatemi M. Application of vibro-acoustography in prostate tissue imaging. Med Phys. 2013 Feb; 40 (2):022902
     View PubMed
182. Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012 Jul; 188(1):58-62. Epub 2012 May 12.
     View PubMed
183. Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012 Jul; 188(1):58-62. Epub 2012 May 12.
     View PubMed
184. Crawford ED, Hirst K, Kusek JW, Donnell RF, Kaplan SA, McVary KT, Mynderse LA, Roehrborn CG, Smith CP, Bruskewitz R. Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trial. J Urol. 2011 Sep; 186(3):965-70. Epub 2011 Jul 24.
     View PubMed
185. Crawford ED, Hirst K, Kusek JW, Donnell RF, Kaplan SA, McVary KT, Mynderse LA, Roehrborn CG, Smith CP, Bruskewitz R. Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trial. J Urol. 2011 Sep; 186(3):965-70. Epub 2011 Jul 24.
     View PubMed
186. Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR. 3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol. 2011 Jul; 22 (7):929-34
     View PubMed
187. Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR. 3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol. 2011 Jul; 22 (7):929-34
     View PubMed
188. Mynderse LA, Roehrborn CG, Partin AW, Preminger GM, Cote EP. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011 May; 185(5):1804-10. Epub 2011 Mar 21.
     View PubMed
189. Mynderse LA, Roehrborn CG, Partin AW, Preminger GM, Cote EP. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011 May; 185(5):1804-10. Epub 2011 Mar 21.
     View PubMed
190. Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010 Nov; 184(5):1907-13. Epub 2010 Sep 17.
     View PubMed
191. Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010 Nov; 184(5):1907-13. Epub 2010 Sep 17.
     View PubMed
192. Woodrum DA, Gorny KR, Mynderse LA, Amrami KK, Felmlee JP, Bjarnason H, Garcia-Medina OI, McNichols RJ, Atwell TD, Callstrom MR. Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. Urology. 2010 Jun; 75 (6):1514.e1-6 Epub 2010 Apr 09
     View PubMed
193. Woodrum DA, Gorny KR, Mynderse LA, Amrami KK, Felmlee JP, Bjarnason H, Garcia-Medina OI, McNichols RJ, Atwell TD, Callstrom MR. Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. Urology. 2010 Jun; 75 (6):1514.e1-6 Epub 2010 Apr 09
     View PubMed
194. McPhail EF, Mynderse LA, Callstrom MR, Gorny KR, McNichols RJ, Atwell TD, Gettman MT, Amrami KK, Kawashima A, Woodrum DA. 1.5T MRI-guided trans-perineal laser ablation of locally recurrent prostate adenocarcinoma. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2010; 7548:754816.
     
195. McPhail EF, Mynderse LA, Callstrom MR, Gorny KR, McNichols RJ, Atwell TD, Gettman MT, Amrami KK, Kawashima A, Woodrum DA. 1.5T MRI-guided trans-perineal laser ablation of locally recurrent prostate adenocarcinoma. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2010; 7548:754816.
     
196. Huidobro C, Larson B, Mynderse S, Myers JJ, Busel D, Acevedo C, Larson TR, Mynderse LA. Characterizing Prostiva RF treatments of the prostate for BPH with gadolinium-enhanced MRI. ScientificWorldJournal. 2009; 9:10-6. Epub 2009 Jan 18.
     View PubMed
197. Huidobro C, Larson B, Mynderse S, Myers JJ, Busel D, Acevedo C, Larson TR, Mynderse LA. Characterizing Prostiva RF treatments of the prostate for BPH with gadolinium-enhanced MRI. ScientificWorldJournal. 2009; 9:10-6. Epub 2009 Jan 18.
     View PubMed
198. Pisansky TM, Gold DG, Furutani KM, Macdonald OK, McLaren RH, Mynderse LA, Wilson TM, Hebl JR, Choo R. High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer. Mayo Clin Proc. 2008 Dec; 83 (12):1364-72
     View PubMed
199. Pisansky TM, Gold DG, Furutani KM, Macdonald OK, McLaren RH, Mynderse LA, Wilson TM, Hebl JR, Choo R. High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer. Mayo Clin Proc. 2008 Dec; 83 (12):1364-72
     View PubMed
200. Mitri FG, Davis BJ, Alizad A, Greenleaf JF, Wilson TM, Mynderse LA, Fatemi M. Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility. IEEE Trans Biomed Eng. 2008 Nov; 55 (11):2584-92
     View PubMed
201. Mitri FG, Davis BJ, Alizad A, Greenleaf JF, Wilson TM, Mynderse LA, Fatemi M. Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility. IEEE Trans Biomed Eng. 2008 Nov; 55 (11):2584-92
     View PubMed
202. Dilger JA, Walsh MT, Warner ME, Mynderse LA, Sprung J. Urethral injury during potassium-titanyl-phosphate laser prostatectomy complicated by transurethral resection syndrome. Anesth Analg. 2008 Oct; 107(4):1438-40.
     View PubMed
203. Dilger JA, Walsh MT, Warner ME, Mynderse LA, Sprung J. Urethral injury during potassium-titanyl-phosphate laser prostatectomy complicated by transurethral resection syndrome. Anesth Analg. 2008 Oct; 107(4):1438-40.
     View PubMed
204. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008 May; 53(5):976-81. Epub 2007 Nov 05.
     View PubMed
205. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008 May; 53(5):976-81. Epub 2007 Nov 05.
     View PubMed
206. Larson BT, Mynderse LA, Somers VK, Jaff MR, Evans WP, Larson TR. Blood pressure surges during office-based transurethral microwave therapy for the prostate. Mayo Clin Proc. 2008 Mar; 83(3):309-12.
     View PubMed
207. Larson BT, Mynderse LA, Somers VK, Jaff MR, Evans WP, Larson TR. Blood pressure surges during office-based transurethral microwave therapy for the prostate. Mayo Clin Proc. 2008 Mar; 83(3):309-12.
     View PubMed
208. Mynderse LA, Larson B, Huidobro C, Meyer JJ, Busel D, Hanson DP, Larson T. Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging. J Endourol. 2007 Nov; 21: (11)1361-6.
     View PubMed
209. Mynderse LA, Larson B, Huidobro C, Meyer JJ, Busel D, Hanson DP, Larson T. Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging. J Endourol. 2007 Nov; 21: (11)1361-6.
     View PubMed
210. Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, Gettman MT, Blute ML. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007 Oct 15; 110 (8):1708-14
     View PubMed
211. Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, Gettman MT, Blute ML. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007 Oct 15; 110 (8):1708-14
     View PubMed
212. Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, Mynderse LA, Choo R, Davis BJ. Prediction of radial distance of extraprostatic extension from pretherapy factors. Int J Radiat Oncol Biol Phys. 2007 Oct 1; 69 (2):411-8
     View PubMed
213. Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, Mynderse LA, Choo R, Davis BJ. Prediction of radial distance of extraprostatic extension from pretherapy factors. Int J Radiat Oncol Biol Phys. 2007 Oct 1; 69 (2):411-8
     View PubMed
214. Siddiqui SA, Mynderse LA, Zincke H, Hoffmann NE, Lobo JR, Wilson TM, Kawashima A, Davis BJ, Blute ML. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007 Jul; 70(1):80-5.
     View PubMed
215. Siddiqui SA, Mynderse LA, Zincke H, Hoffmann NE, Lobo JR, Wilson TM, Kawashima A, Davis BJ, Blute ML. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007 Jul; 70(1):80-5.
     View PubMed
216. Holmes DR, Davis BJ, Hangiandreou NJ, Kinnick RR, Wilson TM, Mynderse LA, Robb RA. Design and testing of a custom transurethral ultrasound device with rapid 3D reconstruction using a rotational scanner. Brachytherapy. 2007 Apr-Jun; 6(2):94.
     
217. Holmes DR, Davis BJ, Hangiandreou NJ, Kinnick RR, Wilson TM, Mynderse LA, Robb RA. Design and testing of a custom transurethral ultrasound device with rapid 3D reconstruction using a rotational scanner. Brachytherapy. 2007 Apr-Jun; 6(2):94.
     
218. Sengupta S, Davis BJ, Mynderse LA, Sebo TJ, Cheville JC, Lohse CM, Hillman DW, Haddock MG, Wilson TM. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy. Urology. 2006 Oct; 68 (4):810-4
     View PubMed
219. Larson BT, Mynderse L, Ulchaker J, Pulling C, Larson TR. Transurethral microwave thermotherapy effectiveness in small prostates. Urology. 2006 Oct; 68(4):790-4.
     View PubMed
220. Larson BT, Mynderse L, Ulchaker J, Pulling C, Larson TR. Transurethral microwave thermotherapy effectiveness in small prostates. Urology. 2006 Oct; 68(4):790-4.
     View PubMed
221. Sengupta S, Davis BJ, Mynderse LA, Sebo TJ, Cheville JC, Lohse CM, Hillman DW, Haddock MG, Wilson TM. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy. Urology. 2006 Oct; 68 (4):810-4
     View PubMed
222. Beckman T, Abu-Lebdeh H, Mynderse L. Erectile dysfunction and testosterone. Mayo Clin Proc.. 2006 Jun; 81: (6)853-4.
     
223. Beckman T, Abu-Lebdeh H, Mynderse L. Erectile dysfunction and testosterone. Mayo Clin Proc.. 2006 Jun; 81: (6)853-4.
     
224. Beckman TJ, Abu-Lebdeh HS, Mynderse LA. Evaluation and medical management of erectile dysfunction. Mayo Clin Proc. 2006 Mar; 81(3):385-90.
     View PubMed
225. Beckman TJ, Abu-Lebdeh HS, Mynderse LA. Evaluation and medical management of erectile dysfunction. Mayo Clin Proc. 2006 Mar; 81(3):385-90.
     View PubMed
226. Beckman TJ, Mynderse LA. Evaluation and medical management of benign prostatic hyperplasia. Mayo Clin Proc. 2005 Oct; 80(10):1356-62.
     View PubMed
227. Beckman TJ, Mynderse LA. Evaluation and medical management of benign prostatic hyperplasia. Mayo Clin Proc. 2005 Oct; 80(10):1356-62.
     View PubMed
228. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Herman MG, King BF, Geyer SM. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Nov 01; 60: (3)767-76.
     View PubMed
229. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Hillman DW, Herman MG, King BF. Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. Cancer J. 2004 Nov-Dec; 10 (6):343-8
     View PubMed
230. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Hillman DW, Herman MG, King BF. Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. Cancer J. 2004 Nov-Dec; 10 (6):343-8
     View PubMed
231. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Herman MG, King BF, Geyer SM. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Nov 01; 60: (3)767-76.
     View PubMed
232. Roehrborn C, Cote E, Larson T, Mynderse L, Partin A, Preminger G. Results of a multicenter trial of a new generation cooled TUMT for BPH. J Urol. 2004; 171(4):402-3.
     
233. Roehrborn C, Cote E, Larson T, Mynderse L, Partin A, Preminger G. Results of a multicenter trial of a new generation cooled TUMT for BPH. J Urol. 2004; 171(4):402-3.
     
234. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, Kim HL, Lugg J, Childs SJ, Shuman B, Jayson MA, Shore ND, Moore Y, Zisman A, Lee JY, Ugarte R, Mynderse LA, Wilson TM, Sweat SD, Zincke H, Belldegrun AS. Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience. J Urol. 2003 Oct; 170(4 Part 1):1126-30.
     View PubMed
235. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, Kim HL, Lugg J, Childs SJ, Shuman B, Jayson MA, Shore ND, Moore Y, Zisman A, Lee JY, Ugarte R, Mynderse LA, Wilson TM, Sweat SD, Zincke H, Belldegrun AS. Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience. J Urol. 2003 Oct; 170(4 Part 1):1126-30.
     View PubMed
236. Mynderse LA, Larson TR. Transurethral hot water balloon thermotherapy for benign prostatic hyperplasia. Curr Urol Rep. 2003 Aug; 4 (4):287-91
     View PubMed
237. Mynderse LA, Larson TR. Transurethral hot water balloon thermotherapy for benign prostatic hyperplasia. Curr Urol Rep. 2003 Aug; 4 (4):287-91
     View PubMed
238. Mynderse LA, Monga M. Oral therapy for Peyronie's disease. Int J Impot Res. 2002 Oct; 14(5):340-4.
     View PubMed
239. Mynderse LA, Monga M. Oral therapy for Peyronie's disease. Int J Impot Res. 2002 Oct; 14(5):340-4.
     View PubMed
240. Martin SA, Mynderse LA, Lager DJ, Cheville JC. Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature. Am J Clin Pathol. 2001 Dec; 116(6):854-63.
     View PubMed
241. Martin SA, Mynderse LA, Lager DJ, Cheville JC. Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature. Am J Clin Pathol. 2001 Dec; 116(6):854-63.
     View PubMed
242. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994 Mar; 151 (3):634-6
     View PubMed
243. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994 Mar; 151 (3):634-6
     View PubMed
244. O'Sullivan DC, Mynderse L, Barrett DM. Subcutaneous port for longterm access and administration of topical chemotherapy to the upper urinary tract. J Urol. 1993 Sep; 150 (3):1034-7
     View PubMed
245. O'Sullivan DC, Mynderse L, Barrett DM. Subcutaneous port for longterm access and administration of topical chemotherapy to the upper urinary tract. J Urol. 1993 Sep; 150 (3):1034-7
     View PubMed
246. O'Sullivan DC, Mynderse LA, Barrett D. Subcutaneous port for long-term access and administration of topical chemotherapy to the upper urinary tract. Journal of Urology (3). 1993 Sep; 150: 1034-7.
     
247. O'Sullivan DC, Mynderse LA, Barrett D. Subcutaneous port for long-term access and administration of topical chemotherapy to the upper urinary tract. Journal of Urology (3). 1993 Sep; 150: 1034-7.
     
248. Mynderse LA, Hassell JR, Kleinman HK, et al. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. Laboratory Investigation. 1983 Mar; 48(3):292-302.
     View PubMed
249. Mynderse LA, Hassell JR, Kleinman HK, et al. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. Laboratory Investigation. 1983 Mar; 48(3):292-302.
     View PubMed
250. Mynderse LA, Martinez-Hernandez A, Kleinman HK, et al. Electron immunohistochemical localization of heparan sulfate in the glomerular basement membrane of nephrotic and normal rats. Federation Proceedings. 1982 Mar 5; 41(4).
     
251. Mynderse LA, Martinez-Hernandez A, Kleinman HK, et al. Electron immunohistochemical localization of heparan sulfate in the glomerular basement membrane of nephrotic and normal rats. Federation Proceedings. 1982 Mar 5; 41(4).